Phenylephrine bitartrate
This article was originally published in The Tan Sheet
Executive Summary
Bayer will submit a citizen petition requesting that FDA reopen the cough/cold nasal decongestants monograph to include PEB, firm says. Company is looking to use the ingredient in Alka-Seltzer Plus effervescent formulations. During a Feb. 15 "feedback" meeting, FDA representatives suggested Bayer either submit a petition to reopen the monograph or file Section 505(b)(2) NDAs for each formulation (1"The Tan Sheet" Feb. 18, 2002, p. 4)...
You may also be interested in...
Phenylephrine Bitartrate Foreign Marketing Data Requested By FDA
Bayer should supply foreign marketing data for phenylephrine bitartrate (PEB) to support its request the ingredient be approved for use as a nasal decongestant, FDA said at a "feedback" meeting in Rockville, Md. Feb. 15
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.